Difference between revisions of "Team:Oxford/Attributions"
| Line 42: | Line 42: | ||
<div class="col-sm-9"> | <div class="col-sm-9"> | ||
<h3>Dr. George Wadhams</h3> | <h3>Dr. George Wadhams</h3> | ||
| − | < | + | <p>Dr. Wadhams has been there for our team since its formation in January. He was essential in helping us assess the viability of our initial ideas and later tailoring our final one that became our project. He has also been there for us during our time in the lab giving us introductions to the cloning protocols we have used.</p> |
</div> | </div> | ||
</div> | </div> | ||
| Line 51: | Line 51: | ||
<h3>Dr. Nicolas Delalez | <h3>Dr. Nicolas Delalez | ||
</h3> | </h3> | ||
| − | < | + | <p>Dr. Delalez has been essential to the success of our team in the lab. He has been our first and last line for help troubleshooting our wet lab problems. He also helped the team learn how to use the fluorescence microscope and plate reader. |
| − | </ | + | </p> |
</div> | </div> | ||
<div class="col-sm-3"> | <div class="col-sm-3"> | ||
| Line 67: | Line 67: | ||
<h3>Professor Judy Armitage | <h3>Professor Judy Armitage | ||
</h3> | </h3> | ||
| − | < | + | <p>Professor Judy Armitage, who has been invaluable to iGEM at Oxford, has been kind enough to let us use her lab over the summer. |
| − | </ | + | </p> |
</div> | </div> | ||
</div> | </div> | ||
| Line 76: | Line 76: | ||
<div class="col-sm-9"> | <div class="col-sm-9"> | ||
<h3>Professor Yves Carlier</h3> | <h3>Professor Yves Carlier</h3> | ||
| − | < | + | <p>Professor Yves Carlier helped guide us in our focus of congenital Chagas disease by highlighting the current issues in diagnostics of acute infections. In addition, he also pointed us towards researching innate immunity and effectiveness of treatment for babies under one year of age. |
| − | </ | + | </p> |
</div> | </div> | ||
<div class="col-sm-3"> | <div class="col-sm-3"> | ||
| Line 89: | Line 89: | ||
<div class="col-sm-9"> | <div class="col-sm-9"> | ||
<h3>Associate Professor Maike Bublitz</h3> | <h3>Associate Professor Maike Bublitz</h3> | ||
| − | < | + | <p>A special thanks to Professor Maike Bublitiz who gave us purified TEV protease to help test the components of our system. She also was kind enough to give a quick introduction to the team on using Nickel NTC columns and using the cell disrupter. |
| − | </ | + | </p> |
</div> | </div> | ||
</div> | </div> | ||
| Line 99: | Line 99: | ||
<h3>Professor Mike Bonsall | <h3>Professor Mike Bonsall | ||
</h3> | </h3> | ||
| − | < | + | <p>Mike Bonsall was essential to our disease model. He taught us about disease modelling including how to make a basic SRI model and a costs model. He also directed us to relevant reading so that we were later able to make our own disease model for our project. |
| − | </ | + | </p> |
</div> | </div> | ||
<div class="col-sm-3"> | <div class="col-sm-3"> | ||
| Line 114: | Line 114: | ||
<h3>Professor Antonis Papachristodoulou | <h3>Professor Antonis Papachristodoulou | ||
</h3> | </h3> | ||
| − | < | + | <p>Professor Papachristodoulou has been very helpful to the modellers on the team, giving them introductions to the ODE and stochastic mo guiding them in the general areas of the ODE and the stochastic models. |
| − | </ | + | </p> |
</div> | </div> | ||
</div> | </div> | ||
| Line 124: | Line 124: | ||
<h3>Harrison Steel | <h3>Harrison Steel | ||
</h3> | </h3> | ||
| − | < | + | <p>Harrison Steel regularly advised the modelling aspects of the project helping the modellers with the minutiae of the stochastic model. </p> |
</div> | </div> | ||
<div class="col-sm-3"> | <div class="col-sm-3"> | ||
Revision as of 13:47, 28 October 2017
Team Attributions
We would like to thank the many people at the University of Oxford and elsewhere without whom, our project would not have been possible.
Special Thanks
Dr. George Wadhams
Dr. Wadhams has been there for our team since its formation in January. He was essential in helping us assess the viability of our initial ideas and later tailoring our final one that became our project. He has also been there for us during our time in the lab giving us introductions to the cloning protocols we have used.
Dr. Nicolas Delalez
Dr. Delalez has been essential to the success of our team in the lab. He has been our first and last line for help troubleshooting our wet lab problems. He also helped the team learn how to use the fluorescence microscope and plate reader.
Professor Judy Armitage
Professor Judy Armitage, who has been invaluable to iGEM at Oxford, has been kind enough to let us use her lab over the summer.
Professor Yves Carlier
Professor Yves Carlier helped guide us in our focus of congenital Chagas disease by highlighting the current issues in diagnostics of acute infections. In addition, he also pointed us towards researching innate immunity and effectiveness of treatment for babies under one year of age.
Associate Professor Maike Bublitz
A special thanks to Professor Maike Bublitiz who gave us purified TEV protease to help test the components of our system. She also was kind enough to give a quick introduction to the team on using Nickel NTC columns and using the cell disrupter.
Professor Mike Bonsall
Mike Bonsall was essential to our disease model. He taught us about disease modelling including how to make a basic SRI model and a costs model. He also directed us to relevant reading so that we were later able to make our own disease model for our project.
Professor Antonis Papachristodoulou
Professor Papachristodoulou has been very helpful to the modellers on the team, giving them introductions to the ODE and stochastic mo guiding them in the general areas of the ODE and the stochastic models.
Harrison Steel
Harrison Steel regularly advised the modelling aspects of the project helping the modellers with the minutiae of the stochastic model.
Additional Thanks
- Sam Bannon, who helped the team prepare and run their first SDS protein gels
- Professor Jaila Dias Borges Lalwani, who directed us towards applying our diagnostic to Bolivia
- Drs David and Carol Harris, who informed the team about the various advantages and disadvantages for the applied design of our project
